NDC 49288-0482
Sugar Cane
Sugar Cane
Sugar Cane is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Sugarcane.
| Product ID | 49288-0482_80e3a713-b3c2-4981-9f01-d987196bc528 |
| NDC | 49288-0482 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sugar Cane |
| Generic Name | Sugar Cane |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | SUGARCANE |
| Active Ingredient Strength | 0 g/mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0482-3
10 mL in 1 VIAL, MULTI-DOSE (49288-0482-3)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0482-4 [49288048204]
Sugar Cane INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0482-3 [49288048203]
Sugar Cane INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0482-2 [49288048202]
Sugar Cane INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0482-5 [49288048205]
Sugar Cane INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0482-1 [49288048201]
Sugar Cane INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SUGARCANE | .05 g/mL |
OpenFDA Data
| SPL SET ID: | addbb916-198c-4992-98c3-a66b19a1e241 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Trademark Results [Sugar Cane]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SUGAR CANE 87132363 not registered Dead/Abandoned |
BBK Tobacco & Foods, LLP 2016-08-09 |
 SUGAR CANE 85204362 4009065 Live/Registered |
BBK Tobacco & Foods, LLP 2010-12-22 |
 SUGAR CANE 78685713 3120334 Live/Registered |
Toyo Enterprise Company Ltd 2005-08-04 |
 SUGAR CANE 78275556 not registered Dead/Abandoned |
Pusser's, West Indies 2003-07-17 |
 SUGAR CANE 76421691 not registered Dead/Abandoned |
CLUB PROVIDENCE, INC, 2002-06-18 |
 SUGAR CANE 75583810 not registered Dead/Abandoned |
Limited Treasures 1998-11-04 |
 SUGAR CANE 73185140 1137659 Dead/Cancelled |
SUGARCANE 1978-09-11 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.